CPR being performed in an ICU setting. Telemetry artifact shows the rate of chest compressions (although not the depth). Arterial line shows the blood pressure achieved during chest compressions.
Quality of CPR makes a difference in perfusion.
#StayinAlive 100/min
Benjamin Abella, MD MPhil

Twitter banned me because they thought I was a bot, X and Elon Musk reinstated me because I am.

A little late to catch up on this wonderful work. I wrote about this in my recent blog post but it didn't gather much attention here (perhaps X's algorithm is to blame). Anyway, I'll post the Brugada syndrome story here as it truly deserves to be highlighted and reach a bigger…

Elmir Omerovic Gregg W. Stone MD Frank Harrell Xuanyu Shi Giulio Grossi Sanjay Kaul Judea Pearl Stephen John Senn John Mandrola, MD The parachute fallacy here. This is not the usual situatiom for decision problems.

⁦David J. Cohen, MD, MSc⁩ talks about the holy grail of leaflet laceration, am so happy I lived to see the IC jargon move upwards from deep throating catheters, to Kissing balloons and now up to the level of holy grail! Just kidding, David shows us the technology of tomorrow now here!

Transcatheter Closure or Surgery for Symptomatic Paravalvular Leaks: The Multicenter KISS Registry. #AHAJournals Eren Karpuzoglu I.H.Tanboga, MD, PhD ahajrnls.org/3U7DsAj

Our article comparing expert analysis and automatic analysis with IVUS in coronary CTA has been accepted by Journal of Cardiovascular CT . Many thanks to my mentor Prof. Christos Bourantas, Anantharaman Ramasamy, I.H.Tanboga, MD, PhD for their contributions.
Doç. Dr. Emrah Erdoğan, Can Yucel Karabay, Turkish Society of Cardiology

SGLT2 inhibitor Therapy Post-MI / Deep dive in DAPA-MI & EMPACT-MI

⭐️Fantastic session &speakers
#CVCT2023 scottdavidsolomon Muthu Vaduganathan BiykemBozkurt CVCT - CardioVascular Clinical Trialists

ORBITA-2

nejm.org/doi/full/10.10…

Bu sinirle konuşmacılara soru sormamalısın😀

twitter.com/NephroGuy/stat…

Our SGLT2 Trialists Consortium meta-analysis *the largest ever* in The Lancet

thelancet.com/journals/lance…

Definitive evidence that SGLT2i ⬇️:
- Kidney failure
- AKI
- CV death
- All-cause death

Regardless of diabetes

Led by Natalie Staplin Richard Haynes Will Herrington

#AHA22

A brief comment on proportional hazard assumption;

Many RCTs use «TIME-TO-EVENT» as a primary endpoint. Cox regression model is used to get summary measure (HR) and 95% CI.
1/

PS is the probability of tx assignment based on baseline covariates. b/c PS idea mimics an RCT, researchers've extensively used.
used PS with caution instead of banning is a solution. In the next tweets, I’m going to specify some critics on PS methods.1/

twitter.com/CMichaelGibson…

Dünyanın en yüksek IF’li dergilerden @JC_ASCO da kabul edilen Oktay Gülcü ,MD kardeşimizin makalesine muhteşem bilimsel ve istatistiksel katlıların için teşekkürler ve tebrikler I.H.Tanboga, MD, PhD
Harikasınız ekip ❤️
Turkish Society of Cardiology

Trials of this year's #AHA that intrigue me the most:
1) SELECT on semaglutide
2) ORBITA-2 on PCI
3) DAPA-MI on dapagliflozin
4) AZALEA on abelacimab
5) ARTESIA on apixaban
6) REMAIN-2 on recaticimab
7) A trial of lepodisiran
8) VERVE-101 on gene editing
sessions.hub.heart.org/aha-23/article…

1/4 Just published our review on how to interpret RCTs focusing on key concepts such as sampling & allocation, uncertainty & variability, relevance & robustness, intention to treat & per protocol, potential outcomes & counterfactuals 👉 mdpi.com/2072-6694/15/1…